Common use of Disclosure and Transfer to Salix of Intellectual Property Clause in Contracts

Disclosure and Transfer to Salix of Intellectual Property. Forthwith following the Effective Date and from time to time during the Initial Term Debiovision: 2.7.1 shall disclose and make available to Salix all Intellectual Property; 2.7.2 acknowledges that all Intellectual Property created, acquired or developed after the Effective Date and during the Initial Term is licensed to Salix under the terms of Clause 2.1; and 2.7.3 shall on request, to the extent legally possible give Salix full access to any regulatory dossier related to a Product filed outside the Territory in connection with Commercialisation of such Product by Salix in the Territory.

Appears in 2 contracts

Sources: Development and License Agreement, Development and License Agreement (Salix Pharmaceuticals LTD)